Pyridine-containing compound catabolic process

pathway activity — cross-omics
GO:0072526Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Pyridine-containing compound catabolic process pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are FGF10, DNAJC18, and THPO, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyridine-containing compound catabolic process activity versus FGF10 in BRCA (Pearson r = -0.08).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCAFGF10 →+1.481+0.126.003.00336
BRCADNAJC18 →+0.361+0.124.004.00236
CCRCCTHPO →+0.781+0.117<.001.00136
PDACNEGR1 →+0.592+0.152.002<.00136
COADASPA →+0.276+0.093.002.00436
BRCACBX7 →+0.715+0.171<.001<.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0072526 vs FGF10 — BRCA

Per-sample scatter of Pyridine-containing compound catabolic process activity vs FGF10 in BRCA.

Explore this scatter interactively →

Exploration